Laser therapy shows promise for chronic Bell's palsy
NCT ID NCT05846217
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a special laser device (Multiwave Locked System) on 84 adults with Bell's palsy that had lasted more than 8 weeks. Participants received laser treatment three times a week for six months. The goal was to see if the laser could improve facial movement and reduce symptoms. The trial compared the real laser to a sham treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Multiwave Locked System laser (class IV NIR laser device)
- What this could lead to
- If it works, this could offer a non-drug treatment option for people with long-lasting Bell's palsy to improve facial function.
- What could go wrong
- This is a small, single-center trial with only 84 participants. The results may not apply to everyone, and the laser device is not widely available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
84 people
The number who actually took part.
- Started
-
May 2021
- Finished
-
Apr 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients were eligible for House-Brackmann grading system (HB) greater than or equal to grade 3. * Patients were adults over 18 years of age and under 60 years of age; * Patients were not received medicine before 2 weeks of trial, such as prednisolone. Exclusion Criteria: * Patients were excluded HB grade 6, or greater than 90% denervation on electroneuronography, or no voluntary electromyography activity, or no latency of early (R1) and late (R2, R2') components in Blink Reflex patients. * Patients were excluded serious mental illness or social problems, and neurological disorders. And systemic disease, such as severe diabetes, malignant tumors, and other serious consumptive diseases, planning for pregnancy, in pregnancy or lactation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bell's palsy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing TongRen Hospital, Capital Medical University
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can targeted exercises and nerve stretching restore a symmetrical smile?
- Facial exercises or mirror tricks: which works better for Bell's palsy?
- Can electric acupuncture waves restore a paralyzed face?
- AI could take the guesswork out of Bell's palsy recovery
- Can tiny needles soothe dry eyes after facial paralysis?
- Facial paralysis hope: new rehab techniques tested